HIV prevention by enhancing compliance of Tenofovir microbicide. Using a novel delivery system

HIV and AIDS Review

Volumn 9, Issue 4, 2010, Pages 105-108

  Shihata, Alfred A ^a   Brody, Steven A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Compliance; Delivery system; FemCap; Microbicide; Tenofovir; Vaginal applicator

Indexed keywords

LUBRICATING AGENT; MICROBICIDE; TENOFOVIR;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATIENT COMPLIANCE; SELF REPORT; SEROCONVERSION; SEXUAL INTERCOURSE; UTERINE CERVIX; VAGINA;

EID: 79551663978     PISSN: 17301270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1730-1270(11)60005-2     Document Type: Article

References (14)

1. Q Abdool Karim, SS Abdool Karim, JA Frohlich, and others. Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women. Science (Abstract). July 19, 2010 (Epub ahead of print).
2. Silvio T, Martinelli D, Germinario C, et.al Determining factors for condom use: A survey of young Italian adults. Eur J Contracept and Reprod. Health Care, 2010; 15:24-30.
3. Crosby RA, Yarber WL, Graham CA, et.al Does it fit okay? Problems with condom use as a function of self-reported poor fit. Sex Transm Infect 2010;86:36-38 doi:10.1136/sti.2009.036665.
4. Van Damme L, Ramjee G, Alary M, et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet 2002; 360: 971-77.
5. Van Damme L, Govinden R, Mirembe F; et.al. Lack of Effectiveness of Cellulose Sulfate Gel for the Prevention of Vaginal HIV Transmission, NEJM Volume 2008; 359:463-472.
6. Salim S, PRO 2000 "HIV Prevention gel proven ineffective in largest clinical trials", Centre for the AIDS Program of Research in South Africa (CAPRISA), University of KwaZulu-Natal, South Africa Future Microbiology 2009 5:4, 527-529.
7. Skoler-Karpoff S, Ramjee G, Ahmed K, et.al. Efficacy of Carraguard for prevention of HIV in women in South Africa. Lancet Vol. 372 Dec. 2008 Pages 1977-1987.
8. Carcio H, Clarke Secor M. Koeniger-Donohue R,. Advanced Health Assessment of Women: Clinical Skills and Procedures Chapter 15 The FemCap. Springer Publishing Company 2010 Pages 271-278.
9. Koeniger-Donohue R, The FemCap A Non-Hormonal Contraceptive, Women's Health Care NPWH.2006 Vol. 5, No 4 pp 79-91.
10. Shihata A, The FemCap™, a new contraceptive choice. Eur J Contracept and Reprod. Health Care, 1998; 3:160-166.
11. Shoupe D, Kjos S,The Handbook of Contraception, Barrier Contraceptives Chapter 10 Humana Press 2006 Pages 147-177.
12. Shihata A, Microbicides Delivery System. 5th European Congress on Tropical Medicine and International Health. Proceedings Amsterdam May 24-28, 2007; 131-134.
13. Shihata A, Novel Delivery System for Microbicides. Presented in 2007 National HIV Prevention Conference. 2007 378.
14. Shihata A, New FDA approved woman-controlled, latex-free barrier contraceptive device "FemCap™". Fertil Steril. International Congress Series 1271 (2004);05.103; 303-306.